Document is current
Any future updates will be listed below
-
Authors
Leerssen, Jeanne https://orcid.org/0000-0001-9581-0388
Blanken, Tessa F. https://orcid.org/0000-0003-1731-0251
Pozzi, Elena
Jahanshad, Neda https://orcid.org/0000-0003-4401-8950
Aftanas, Lyubomir
Andreassen, Ole A.
Baune, Bernhard T.
Brack, Ivan https://orcid.org/0000-0002-5146-0096
Carballedo, Angela
Ching, Christopher R. K.
Dannlowski, Udo
Dohm, Katharina
Enneking, Verena
Filimonova, Elena
Fingas, Stella M.
Frodl, Thomas https://orcid.org/0000-0002-8113-6959
Godlewska, Beata R.
Goltermann, Janik
Gotlib, Ian H. https://orcid.org/0000-0002-3622-3199
Grotegerd, Dominik
Gruber, Oliver
Harris, Mathew A. https://orcid.org/0000-0002-1135-4141
Hatton, Sean N.
Hawkins, Emma
Hickie, Ian B.
Jaworska, Natalia https://orcid.org/0000-0001-5643-8210
Kircher, Tilo
Krug, Axel https://orcid.org/0000-0002-0564-2497
Lagopoulos, Jim
Lemke, Hannah
Li, Meng
MacMaster, Frank P.
McIntosh, Andrew M. https://orcid.org/0000-0002-0198-4588
McLellan, Quinn https://orcid.org/0000-0003-3806-2218
Meinert, Susanne
Mwangi, Benson
Nenadić, Igor
Osipov, Evgeny https://orcid.org/0000-0002-4961-296X
Portella, Maria J.
Redlich, Ronny
Repple, Jonathan
Sacchet, Matthew D.
Sämann, Philipp G.
Simulionyte, Egle
Soares, Jair C.
Walter, Martin
Watanabe, Norio
Whalley, Heather C. https://orcid.org/0000-0002-4505-8869
Yüksel, Dilara
Veltman, Dick J.
Thompson, Paul M.
Schmaal, Lianne https://orcid.org/0000-0001-9822-048X
Van Someren, Eus J. W.
- License Information
-
More Information
Article History
Received: 8 April 2020
Revised: 4 November 2020
Accepted: 17 November 2020
First Online: 8 December 2020
Conflict of interest
: I.B.H. has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca) projects focused on the identification and better management of anxiety and depression. He was a member of the Medical Advisory Panel for Medibank Private until October 2017, a Board Member of Psychosis Australia Trust, and a member of Veterans Mental Health Clinical Reference group. He is the Chief Scientific Advisor to, and an equity shareholder in, Innowell. Innowell has been formed by the University of Sydney and PwC to deliver the $30 m Australian Government-funded “Project Synergy.” Project Synergy is a 3-year program for the transformation of mental health services through the use of innovative technologies. C.R.K.C. received partial research support from Biogen, Inc. (Boston, USA) for work unrelated to the topic of this manuscript. The other authors report no financial relationships with commercial interests.
